Familial Mediterranean fever in northwest of Iran (Ardabil): The first global report from Iran

Turkish Journal of Pediatrics

Volumn 50, Issue 1, 2008, Pages 40-44

  Salehzadeh, Farhad ^a   Emami, Dina ^a   Zolfegari, Ali Asgar ^b   Yazdanbod, Abas ^a   Habibzadeh, Sharam ^a   Bashardost, Bahman ^a   Barak, Manuchehr ^a   Feizi, Iraj ^a   Azimi, Hormoz ^b   Jastan, Marina ^a   Khalafi, Jafar ^a  

^a ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Colchicine; Familial Mediterranean fever; Periodic fever syndromes

Indexed keywords

ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; COLCHICINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; DELAYED DIAGNOSIS; DIAGNOSTIC ERROR; DIARRHEA; FAMILIAL MEDITERRANEAN FEVER; FAMILY HISTORY; FEMALE; FEVER; GEOGRAPHIC DISTRIBUTION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INTERVIEW; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ONSET AGE; QUESTIONNAIRE; SEX RATIO; SURGICAL ERROR;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COLCHICINE; CONSANGUINITY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GOUT SUPPRESSANTS; HUMANS; INFANT; IRAN; MALE; MIDDLE AGED; PAIN MEASUREMENT; QUESTIONNAIRES;

EID: 41949120422     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bakkaloǧlu A. Familial Mediterranean fever. Pediatr Nephrol 2003; 18: 853-859.
2. Medlej-Hashim M, Loiselet J, Lefranc G, Megarbane A. Familial Mediterranean fever (FMF): from diagnosis to treatment. Sante 2004; 14: 261-266.
3. Joost PH. A brief history of our understanding of periodic fever syndromes. Am J Med Sci 2003; 110: 629.
4. Pras M, Kastner D. Juvenile chronic arthritis: familial Mediterranean fever. In: Klippel JH, Dieppe PA (eds). Textbook of Rheumatology, Vol 1 (2nd ed). London: Mosby; 1999: 23.1-4.
5. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998; 351: 659-664.
6. Meyerhoff J. Familial Mediterranean fever: report of a large family, review of the literature and discussion of the frequency of amyloidosis. Medicine 1980; 59: 66-77.
7. Zaks N, Shinar Y, Padeh S, et al. Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever. Isr Med Assoc J 2003; 5: 585-588.
8. Dabak R, Uygur-Bayramicli O, Aydin DK, et al. Encapsulating peritonitis and familial Mediterranean fever. World J Gastroenterol 2005; 11: 2844-2846.
9. Kastner D. Familial Mediterranean fever and other hereditary recurrent fevers. In: Kasper D, Braunwald E, Fauci A, Hauser S, Longo D, Jameson JL (eds). Harrison's Principles of Internal Medicine, Vol 2 (16th ed). USA: McGraw Hill; 2005: 1793-1795.
10. Brik R, Shinawi M, Kepten I, Berant M, Gershoni-Baruch R. Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 1999; 103: e70.
11. Ben-Chetrit E. Familial Mediterranean fever (FMF) and renal AA amyloidosis - phenotype-genotype correlation, treatment and prognosis. J Nephrol 2003; 16: 431-434.
12. Musabak U, Sengul A, Oktenli C, et al. Does immune activation continue during an attack-free period in Familial Mediterranean fever? Clin Exp Immunol 2004; 138: 526-533.
13. Bagci S, Toy B, Tuzun A, et al. Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 2004; 23: 333-337.
14. Oktem S, Yavuzsen TV, Sengul B, Akhunlar H, Akar S. Tunca M. Level of interleukin-6 (IL-6) and its soluble receptor (sIL-6R) in familial Mediterranean fever (FMF) patients and their first degree relatives. Clin Exp Rheumatol 2004; 22(Suppl): S34-36.
15. Nucera G, La Regina M, Diaco M, Neri G, Gasbarrini G, Manna R. Familial Mediterranean fever: an ancient hereditary disease. Ann Ital Med Int 2003; 18: 136-148.
16. Bodur H, Ucan H, Seckin S, Seckin U, Gunduz OH. Protracted familial Mediterranean fever arthritis. Rheumatol Int 1999; 19: 71-73.
17. Besbas N, Ozdemir S, Saatci I, Bakkaloglu A, Ozen S, Saatci U. Sacroiliitis in familial Mediterranean fever: an unusual presentation in childhood. Turk J Pediatr 1999; 41: 387-390.
18. Majeed HA, Al-Qudah AK, Qubain H, Shahin HM. The clinical patterns of myalgia in children with familial Mediterranean fever. Semin Arthritis Rheum 2000; 30: 138-143.
19. Barzilai A, Langevitz P, Goldberg I, et al. Erysipelas-like erythema of familial Mediterranean fever: clinicopathologic correlation. J Am Acad Dermatol 2000; 42: 791.
20. Majeed HA, Ghandour K, Shahin HM. The acute scrotum in Arab children with familial Mediterranean fever. Pediatr Surg Int 2000; 16: 72-74.
21. Deltas C, Kanakoudi F, Pratsidou J. Familial Mediterranean fever. I Rheumatol Int 2000; 18: 70.
22. Delague V, Kriegshauser G, Oberkanins C, Megarbane A. Reverse hybridization vs. DNA sequencing in the molecular diagnosis of familial Mediterranean fever. Genet Test 2004; 8: 65-68.
23. Karalova EM, Abroian LO, Akopian I.O, Karageian KG, Magakian IuA. Nuclei and nucleolar organizing regions in chromosomes of lymphocytes on different stages of periodic disease. Tsitologiia 2004; 46: 376-380.
24. Frenkel J, Kuis W. Overt and occult rheumatic diseases: the child with chronic fever. Best Pract Res Clin Rheumatol 2002; 16: 443-469.
25. Rozenbaum M, Rosner I. Severe outcome of juvenile idiopathic arthritis (JIA) associated with familial Mediterranean fever (FMF). Clin Exp Rheumatol 2004; 22(Suppl): S75-78.
26. Kadayifci A, Uygun A, Daǧalp K, Kepekci Y. The coexistence of familial Mediterranean fever and Addison disease. J Clin Gastroenterol 1999; 30: 98-99.
27. Cattan D, Notarnicola C, Molinari N, Touitou I. Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever. Lancet 2000; 355: 378-379.
28. Demirtürk L, Özel AM, Cekem K, Yazgan Y, Gültepe M. Co-existence of Helicobacter pylori infection in patients with familial Mediterranean fever (FMF) and the effect of Helicobacter pylori on the frequency and severity of FMF attacks. Dig Liver Dis 2005; 37: 153-158.
29. Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A. Behcet's disease in familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 2000; 29: 286-295.
30. Imirzaliolgu N, Dursun A, Tastan B, Soysal Y, Yakicier MC. MEFV gene is a probable susceptibility gene for Behçet's disease. Scand J Rheumatol 2005; 34: 56-58.
31. Lidor M, Scherrmann JM, Shinar Y, et al. Colchicine nonresponsiveness in familial Mediterranean fever. Clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum 2004; 33: 273-282.
32. Lidar M, Kedem R, Langevitz P, Pras M, Livneh A. Intravenous colchicine for treatment of patients with familial Mediterranean fever unresponsive to oral colchicine. J Rheumatol 2003; 30: 2620-2623.
33. Tunca M, Tankurt E, Akbaylar Akpinar H, Akar S. Hizli N. Gönen O. The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: a pilot study. Br J Rheumatol 1997; 36: 1005-1008.
34. Özgöçmen S, Özçakar L, Ardiçoǧlu O, Kocakoç E. Kaya A. Kiris A. Familial Mediterranean fever responds well to infliximab: single-case experience. Clin Rheumatol 2006; 25: 83-87. Epub 2005 Sep 20.
35. Salehzadeh F, Shahroz A. FMF and new neurologic findings in pediatrics. 7th International Pediatric Congress 1995; Tehran, Iran: 249.